Chester County-based Gene Therapy Company Announces First Patient Dosed in Trial for Treatment of Localized Scleroderma
EXTON, PA — Castle Creek Biosciences, Inc, a privately-held, clinical-stage cell and gene therapy company leveraging its proprietary fibroblast technology platform to develop and commercialize innovative personalized therapies for underserved …
Read More